Base Year
Historical Year
Forecast Year
The global meningococcal vaccines market stood at 172 million doses in 2020. The global meningococcal vaccines market is expected to grow at a healthy pace in the forecast period of 2024-2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market growth of meningococcal vaccines is being driven by the rising prevalence of various types of bacteria that trigger meningococcal meningitis. The most common among them are A, B, C, W, Y, and type X that was lately tracked in Africa. This is aiding the market growth of meningococcal vaccines as the demand for effective meningococcal vaccines is on the rise over the forecast period. The market is further being propelled by the extremely unpredictable dissemination of this bacteria and fluctuating occurrences of the disease over time and across different age groups and geographies, which has resulted in a considerable increase in the frequency of clinical programmes for the development of efficient meningococcal vaccines worldwide. Moreover, several ongoing clinical programmes for the development of meningococcal vaccines at varying stages is further facilitating the market growth globally.
Meningococcal meningitis is a rare and potentially disturbing bacterial infection that affects the brain. Even after the advances in the medical field, the disease has the potential to take the life of the host in a relatively lesser timespan. Meningococcal vaccines are produced as the prevention of meningococcal meningitis.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of type, the market is divided into:
Based on age group, the industry can be segmented into:
By distribution channel, the industry is categorised into:
These segments are further divided on the basis of type. Institutional sales are divided into hospitals, community clinics, and public health agencies, whereas retail sales are divided into retail pharmacy and online, among others.
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market growth of meningococcal vaccines is being driven by the rising initiatives like National Immunization Programs (NIPs) by the governments and supported by private non-profit organisations for the development of meningococcal vaccines. Further, the addition of meningococcal vaccines to NIPs with the motive to ascertain vaccine supply affordability and sustainability in public and private sectors has been generating an abundance of opportunities for the manufacturers.
The report gives a detailed analysis of the following key players in the global meningococcal vaccines market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Age Group |
|
| Breakup by Brand |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2020, the global meningococcal vaccines market attained 172 million doses.
The major drivers of the industry, such as rising disposable incomes, increasing population, rising prevalence of the disease, and increasing demand for effective meningococcal vaccines, are expected to aid the market growth.
The key market trend guiding the growth of the industry includes the rise in the initiatives undertaken by the government.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading types of meningococcal vaccines in the market are polysaccharide vaccine (MPSV4), conjugate vaccine (MCV4), and serogroup B vaccine (MenB-FHpb/MenB-4C).
The major age groups considered in the market report are infants, children, and adults, among others.
The significant distribution channels in the industry are institutional sales and retail sales.
The major players in the industry are Pfizer Inc., Sanofi SA, GlaxoSmithKline plc, and Incepta Vaccine Ltd., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share